/cloudfront-us-east-2.images.arcpublishing.com/reuters/QFWUTH5BLZN5LGWVT27LGWPZBE.jpg "Roche arthritis drug reduces COVID-19 deaths in trial in hospitalised patients | Reuters")
Roche arthritis drug reduces COVID-19 deaths in trial in hospitalised patients | Reuters
Sickest coronavirus patients to be treated with arthritis drugs after study finds reduction in death rates - ABC News
FDA Advisory No.2021-2406 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product “Actemra® Tocilizumab 400 mg/ 20 mL” - Food and Drug Administration
Tocilizumab: un fármaco en monopolio para tratar COVID-19 sin eficacia probada - Salud con lupa
Roche to boost Tocilizumab supply to meet rising demand in India - The Economic Times
Roche's Actemra fails to meet Phase III goals in Covid-19 patients
Tocilizumab Plus Remdesivir to Be Evaluated for Severe COVID-19 Pneumonia
Roche won't contest Hetero Drug's tocilizumab copy | Mint
Actemra Lawsuits | Case Evaluations, Deaths & FDA Review
Roche Suspends Patents On Tocilizumab In LMICs After WHO Recommends It As Treatment For Severe COVID-19 - Health Policy Watch
Tocilizumab Shortage Continues as Pandemic Wears On
FDA approves drug to treat CRS induced by CAR T-cell therapy | MDedge Hematology and Oncology
USTC Global on Twitter: "The mechanism of using Tocilizumab to cure severe patients of COVID-19. @NIH @CDC @DrAiLynTan #coronavirus #COVID19 #CoronavirusOutbreak #coronaviruskorea #ItalyCoronavirus #italylockdown #IranCoVidTruth #Tocilizumab https://t ...
Health System News Teamwork Tackles Tocilizumab
Roche Arthritis Drug Fails Covid-19 Testing - WSJ
Roche gives Tocilizumab worth over Rs 40 crores to MoHFW - Express Pharma
%20400%20mg_20%20mL253e948d-03f9-4810-a763-a2ce009aaf4b.GIF "Roche Products & Contact Information | MIMS Malaysia")
Roche Products & Contact Information | MIMS Malaysia
CHMP backs expanded approval of tocilizumab | MDedge Hematology and Oncology
Approval lapsed) RoActemra tocilizumab 80mg/4mL concentrate for solution for infusion (Roche Germany) | Therapeutic Goods Administration (TGA)
Tocilizumab, un medicament folosit pentru artrită, reduce riscul de deces la pacienții cu forme grave de COVID (studiu) | Digi24
Coronavirus : l'Actemra de Roche marque un point contre le Covid 19 | Les Echos
Genentech's arthritis drug tocilizumab shows promise in Covid-19 trial
Roche to boost Tocilizumab supply to meet rising demand in India - The Economic Times
Genentech moves Actemra into phase III COVID-19 trial | 2020-03-19 | BioWorld
Delhi HC Issues Order on Tocilizumab Shortage, Seeks Patent Working Information from Roche – Spicyip
Tocilizumab (Actemra)
